Biora Therapeutics, Inc.
BIOR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -98.7% | -75.5% | -98.3% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 100% | 100% | -25.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,851,350% | -12,246.9% | -13,197% | -142.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,102,875% | -12,510.5% | -14,316% | -259.1% |
| EPS Diluted | -78.7 | -6.4 | -46.42 | -86.3 |
| % Growth | -1,129.7% | 86.2% | 46.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |